A Phase 3b, Open-Label, Safety and Immunogenicity Study of SARS-CoV-2 mRNA-1273 Vaccine in Adult Solid Organ Transplant Recipients and Healthy Controls
Administered By
Awarded By
Contributors
- Beerman, Rebecca Clinical Data Manager
- Montefiori, David Charles Principal Investigator
- Sarzotti-Kelsoe, Marcella Director
- Shen, Xiaoying Co Investigator
Start/End
- June 9, 2021 - March 31, 2023